Oppenheimer has published a research report on Clorox (NYSE:
CLX).
In the report, Oppenheimer wrote, "Throughout our recent meeting, Clorox senior management expressed optimism
regarding its momentum exiting fiscal 2011, and that its two primary headwinds—market growth and commodity costs—are moving in the right direction, while characterizing fiscal 2012 guidance as conservative."
Oppenheimer rated Clorox a Perform with no price target given. Clorox closed Wednesday at $65.28.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
